ASHA P JOHNSON

Dr. ASHA P JOHNSON

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2021 in Materials
Verified
Journal Article
Open access
PDF file
MRMohamed Rahamathulla
Mohamed Rahamathulla
RBRohit R. Bhosale
Rohit R. Bhosale
RORiyaz Ali M Osmani
Riyaz Ali M Osmani
KMKasturi C. Mahima
Kasturi C. Mahima
AJASHA P JOHNSON
ASHA P JOHNSON
HGH.V. Gangadharappa
H.V. Gangadharappa
Current discoveries as well as research findings on various types of carbon nanostructures have inspired research into their utilization in a number of fields. These carbon nanostructures offer uses in pharmacy, medicine and different therapies. One such unique carbon nanostructure includes carbon nanotubes (CNTs), which are one-dimensional allotropes of carbon nanostructure that can have a length-to-diameter ratio greater than 1,000,000. After their discovery, CNTs have drawn extensive research attention due to their excellent material properties. Their physical, chemical and electronic properties are excellent and their composites provide great possibilities for enormous nanometer applications. The current study provides a systematic review based on prior literature review and data gathered from various sources. The various research studies from many research labs and organizations were systematically retrieved, collected, compiled and written. The entire collection and compilation of this review concluded the use of CNT approaches and their efficacy and safety for the treatment of various diseases such as brain tumors or cancer via nanotechnology-based drug delivery, phototherapy, gene therapy, antiviral therapy, antifungal therapy, antibacterial therapy and other biomedical applications. The current review covers diverse applications of CNTs in designing a range of targeted drug delivery systems and application for various therapies. It concludes with a discussion on how CNTs based medicines can expand in the future.

18 February 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
RARavi Kiran Ammu
Ravi Kiran Ammu
KGKusuma Kumari Garikapati
Kusuma Kumari Garikapati
PKPraveen T. Krishnamurthy
Praveen T. Krishnamurthy
AJASHA P JOHNSON
ASHA P JOHNSON
MKMadhuchandra Kenchegowda
Madhuchandra Kenchegowda
Syed Mohd Danish RizviSyed Mohd Danish Rizvi
Syed Mohd Danish Rizvi
Pediatric brain tumors are the major cause of pediatric cancer mortality. They comprise a diverse group of tumors with different developmental origins, genetic profiles, therapeutic options, and outcomes. Despite many technological advancements, the treatment of pediatric brain cancers has remained a challenge. Treatment options for pediatric brain cancers have been ineffective due to non-specificity, inability to cross the blood–brain barrier, and causing off-target side effects. In recent years, nanotechnological advancements in the medical field have proven to be effective in curing challenging cancers like brain tumors. Moreover, nanoparticles have emerged successfully, particularly in carrying larger payloads, as well as their stability, safety, and efficacy monitoring. In the present review, we will emphasize pediatric brain cancers, barriers to treating these cancers, and novel treatment options.